The likelihood of chemotherapy being cost-effective for patients with metastatic prostate cancer differs across racial subgroups. This uncertainty presents challenges for managed-care decision makers.
Rahul Jain, PhD
Advertisement
Articles by Rahul Jain, PhD
Advertisement
Latest Updated Articles
- Racial Variation in the Cost-effectiveness of Chemotherapy for Prostate Cancer
Published: May 18th 2011 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Medicare State Rankings Reveal Stark Differences in Access, Quality, and Affordability
2
mRNA COVID-19 Vaccines Not Associated With Major Congenital Malformations During Pregnancy
3
In Its 50th Year, ESMO Comes to Berlin, a City Transformed
4
Physical Activity, Vaccination May Protect Against Long COVID
5
